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North American Indian childhood cirrhosis (CIRH1A, or NAIC), a severe autosomal recessive intrahepatic cho-
lestasis described in Ojibway-Cree children from northwestern Quebec, is one of several familial cholestases with
unknown molecular etiology. It typically presents with transient neonatal jaundice, in a child who is otherwise
healthy, and progresses to biliary cirrhosis and portal hypertension. Clinical and physiological investigations have
not revealed the underlying cause of the disease. Currently, liver transplantation is the only effective therapy for
patients with advanced disease. We previously identified the NAIC locus by homozygosity mapping to chromosome
16q22. Here we report that an exon 15 mutation in gene FLJ14728 (alias Cirhin) causes NAIC: c.1741CrT in
GenBank cDNA sequence NM_032830, found in all NAIC chromosomes, changes the conserved arginine 565
codon to a tryptophan, altering the predicted secondary structure of the protein. Cirhin is preferentially expressed
in embryonic liver, is predicted to localize to mitochondria, and contains WD repeats, which are structural motifs
frequently associated with molecular scaffolds.
North American Indian childhood cirrhosis (CIRH1A
or NAIC [MIM 604901]) is a distinct form of severe
familial cholestasis of unknown etiology (Arnell et al.
1997; Drouin et al. 2000a; Jacquemin 2000; Chen et al.
2001) described in Ojibway-Cree aboriginal children in
the Abitibi region of northwestern Quebec (Drouin et
al. 2000b). The disease typically presents with transient
neonatal jaundice, in a child who is otherwise well, and
progresses to biliary cirrhosis and portal hypertension.
Biochemical and histopathological features of the disease
suggest involvement of the bile ducts rather than of the
bile canaliculi. They include elevated gamma glutamyl
transferase and alkaline phosphatase levels, and, typi-
cally, marked fibrosis around portal bile ducts. Clinical
and physiological investigations have not revealed the
underlying cause of NAIC. Currently, liver transplan-
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tation is the only effective therapy for patients with ad-
vanced disease.
In a previous study (Betard et al. 2000), we localized
the gene responsible for autosomal recessive intrahepat-
ic cholestasis NAIC/CIRH1A to chromosome 16q22,
through use of a genomewide scan. A common 4.9-cM
haplotype was found to be shared and homozygous in
all patients with NAIC and was flanked on the cen-
tromeric side by D16S3398 and on the telomeric side
by D16S512 (Betard et al. 2000). Analysis of additional
markers in an enlarged cohort allowed us to narrow this
conserved ancestral haplotype to a 2.4-Mb region be-
tween D16S3085 and D16S3095 (fig. A [online only]).
According to the Human Genome ProjectWorkingDraft
(UCSC Genome Bioinformatics Web site), this region
contains 45 genes of known and unknown function.
Using the BigDye Terminator Cycle Sequencing Kit
(Applied Biosystems), we sequenced the coding region,
splice junctions, flanking intronic sequence, and ∼1 kb of
the putative promoters of all 27 genes known to be ex-
pressed in liver (on the basis of EST sources listed in
UniGene) (fig. A [online only]). Nineteen of these were
located between the two recombinantmarkersD16S3085
and D16S3095. Initially, six samples were sequenced (pa-
tient DNA pool, obligate heterozygote DNA pool, two
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Figure 1 Mutation detection. A, Electropherogram of patient (top), parent (middle), and control subject (bottom). At the bottom, the
amino acid sequence corresponding to this DNA region is shown. The NAIC mutation changes an arginine codon to a tryptophan codon. B,
Detection of the NAIC mutation by a PCR-RFLP test. The NAIC mutation creates an AluI restriction site. Exon 15 of the FLJ14728 gene was
amplified by PCR using forward primer 5′-AAT GCC CTT CTG GTC TTT CTG and reverse primer 5′-CGC AAA GTA GAC AAA TAG TCA.
PCR was performed under the following conditions: 95C for 5 min, followed by 35 cycles of 95C for 45 s, 58C for 30s, and 72C for 45s.
The amplicon was digested with AluI, and the digestion products were separated on 3.0% agarose gels. The PCR fragment also contains a
constant internal AluI site that serves as a positive control for digestion and that yields a 150-bp fragment. Lanes 1–3, patients with NAIC;
lanes 4–6, heterozygous parents; lanes 7–10, homozygous normal individuals.
NAIC individual patient DNAs, a DNA sample from
a patient’s mother, and a CEPH control [individual
NA07057, CEPH/Utah pedigree 1331 from CORIELL]).
Informative variants (heterozygous parents and homo-
zygous patients) were genotyped by sequencing or by
PCR-RFLP in all samples from the five families with
NAIC (22 patients, 22 parents, and 30 siblings).
Multiple alignments of DNA sequences, obtained us-
ing Sequencher software (version 4.0.5; Gene Codes),
allowed us to identify 88 SNPs, 57 of which were located
between D16S3085 and D16S3095. Eighty-seven SNPs
either were located in introns or were neutral exonic
variants.
Only one gene inside the NAIC critical region (en-
coding hypothetical protein FLJ14728; UniGene cluster
Hs.151001) contained a missense mutation that could
have a functional effect and could be the cause of NAIC.
This mutation was located in exon 15 of the cDNA
sequence NM_032830 (c.1741CrT) or in BAC genomic
sequence AC009131 (g.59305CrT) (fig. 1A) and sub-
stitutes a tryptophan for a conserved arginine at codon
565 (R565W). FLJ14728 has 17 exons spanning 36.3
kb of genomic sequence and is flanked by the syntrophin,
beta 2 (SNTB2), and hyaluronan synthase 3 (HAS3)
genes (fig. A [online only]). The transcript is 2,192 bp
with a single ORF of 2,060 bp encoding a 686–amino
acid protein (GenBank accession number NP_116219).
We named the gene encoding FLJ14728 “Cirhin.”
We confirmed the association of this mutation with
the transmission of NAIC by sequencing 74 individuals
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Figure 2 Partial amino acid sequences of Cirhin and its homologues in vertebrates. The underlined arginine (R) is the residue mutated
in patients with NAIC. Multiple sequence alignment was performed using the ClustalW alignment tool with Blosum weight matrix at the Baylor
College of Medicine Search Launcher Web site. To generate the output, we used BoxShade 3.21 (BoxShade Server Web site). All homologous
protein sequences (GenBank ID numbers shown) were originally identified by tblastn analysis at the NCBI BLAST Home Page, using the
FLJ14728 protein sequence (GenBank accession number NP_116219 ) as a query against EST databases. In the residue numbering, 1 is the
first amino acid in each of the predicted proteins.
from the five families with NAIC. All patients (np
) were T/T homozygotes. The observation that the22
homozygous missense mutation was absent in all un-
affected family members, since all parents ( ) werenp 22
heterozygous (T/C), and that the 30 unaffected siblings
were either heterozygous (21/30) or C/C homozygous
(9/30), lends support to our assertion that this is a dis-
ease-causing mutation.
To determine the frequency of the NAIC c.1741CrT
mutation in different populations, we genotyped 367
control DNAs by means of a simple PCR-RFLP assay,
which exploits the presence of an AluI restriction site
created by the mutant allele (fig. 1B). This PCR-RFLP
assay will be particularly useful as a mutation screening
test in at-risk families. The DNA samples were obtained
from 122 unrelated individuals from the province of
Quebec, 120 CEPH parents, 56 Ojibway-Cree Indians
with no known relationship to the families with NAIC,
25 Nadene Indians, 10 Mexican Americans, 10 South
American Indians, and 24 DNAs from the M24PDR
panel obtained from Coriell Cell Repositories (with
DNA samples from European Americans, African Amer-
icans, Mexican Americans, Asian Americans, andNative
Americans).
Only a single c.1741CrT allele was discovered in a
Mexican American individual. Investigation of SNPs in
genes closely linked to Cirhin—including the nuclear fac-
tor of activated T cells, cytoplasmic, calcineurin-depen-
dent 3 (NFATC3), cadherin 3 (CDH3), SNTB2, and vac-
uolar protein sorting 4A (VPS4) genes—indicates that the
c.1741CrT variation observed in this individual is on a
different haplotype (data not shown), pointing to an or-
igin that is likely to be independent from that of the Ojib-
way-Cree NAIC mutation. Thus, our identification of 1
mutant allele among 734, including at least 182 alleles
from Native Americans, suggests that the mutation arose
spontaneously in this sample and was not the result of
Native American admixture. Of note, the normal C nu-
cleotide is within a CpG dinucleotide, a known muta-
tional hotspot (Templeton et al. 2000). In spite of this,
the demonstration of a R565W Cirhin mutation in a
non–Ojibway-Cree individual suggests that the Cirhin
gene should be investigated in cases of nonsyndromic cho-
lestasis clinically similar to NAIC.
In the BLAST analysis of the Cirhin gene sequence
against all available databases, the mutant allele was
absent from 101 different mammalian sequences (BAC
AC009131, 64 human ESTs, 14 human cDNAs, 17
mouse ESTs, and 5 rat ESTs). This confirmed that the
NAIC mutation is rare in the general population.
Cirhin has no known human paralogs. The murine
ortholog is UniGene cluster Mm.10665. Using Se-
quencher, we assembled all mouse ESTs of this cluster,
to determine the mouse coding sequence, which is 89%
identical to the human sequence. In the deduced amino
acid sequence of Cirhin in mice and other vertebrates,
R565 is highly conserved (fig. 2).
In Saccharomyces cerevisiae, an ORF on chromosome
IV (YDR324c) encodes a 776-residue protein of un-
known function, with 23% amino acid identity to Cir-
hin. The amino acid position equivalent to R565 in hu-
man Cirhin is occupied by another dibasic amino acid,
lysine. This suggests that the basic residue arginine may
be functionally significant and that mutation to the ar-
omatic amino acid tryptophan probably affects the func-
tion of the protein. Strains of S. cerevisiae deleted for
Figure 3 Embryonic expression of Cirhin. In situ hybridization on a sagittal section of a day-11.5 mouse embryo with a 3′ probe showed
prominent expression of Cirhin in the liver (arrow) and much weaker levels in the somites, brain, and craniofacial structures. Probe 1 specific
to the 5′ portion of Cirhin gave identical results, whereas the corresponding sense probes showed no detectable signals. The mouse primer
sequences for amplification by RT-PCR of probe 1 (5′ fragment of the gene) are 5′-CAG ATT GGC TGT TTC ACG AAC and TGT TGC CTA
TCT AAA ACC ATC, and those for probe 2 (3′ fragment) are 5′-CTT TCC AGC CGC AGT CAG GTA and 5′-CCG CCT CAA GAA GAC
ATC TGA T. Total adult mouse liver RNA was used as a template for the RT-PCRs.
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YDR324c are nonviable (Winzeler et al. 1999). Because
of the nonviable phenotype in yeast lacking the Cirhin
ortholog, it is possible that complete Cirhin deficiency
may be lethal in mammals and that mutant Cirhin con-
taining R565W has partial activity.
To determine the effect of the c.1741CrT allele on
gene expression, we compared the intensity of a 600-nt
RT-PCR fragment from the 3′ portion of Cirhin through
use of liver RNA of a patient with NAIC and a control
individual. The expression levels were equivalent (data
not shown). Patients with NAIC have neonatal jaundice
(Drouin et al. 2000b), consistent with an abnormality
of prenatal liver development. To determine whether the
NAIC gene could play an important role in liver em-
bryogenesis, we used in situ hybridization to investigate
the gene expression pattern during mouse embryonic
development. The two murine NAIC probes used in
these experiments were generated from the 5′ and 3′ por-
tions of the gene. Since there is no complete mouse ho-
mologue in GenBank, we obtained the virtual mouse
sequence by comparing the human FLJ14728 sequence
(GenBank accession number NM_032830) to the mouse
EST database, through use of BLAST (NCBI BLAST
Home Page). Two different mouse ESTs, both from
UniGene cluster Mm.10665, were used as templates for
designing the RT-PCR primers. Indeed, in situ hybridi-
zation in day-11.5 mouse embryos shows that Cirhin is
highly and predominantly expressed in liver, with lower
levels of expression in somites, brain, and craniofacial
structures (fig. 3), whereas the corresponding sense
probe showed only background signal (data not shown).
Cirhin expression showed a significant decrease in day-
12.5 embryos and in the newborn, but we observed de-
tectable levels of mRNA in newborn and adult mouse
liver by RT-PCR (data not shown).
The secondary structure of the Cirhin protein was
predicted through use of Internet tools, including Ex-
PASy (ExPASy Molecular Biology Server). Cirhin has a
predicted molecular weight of 77 kD, with a theoretical
isoelectric point of 9.03. iPSORT (iPSORT Home Page)
predicts the presence of an N-terminal mitochondrial
targeting peptide for Cirhin. The R565W substitution
resulting from the NAIC mutation replaces an isolated
a-helical domain with an extended strand conformation
in the predicted 2-D structure of the protein determined
at theWeb-based Protein Sequence Analysis (PSA) Server
and at the Network Protein Sequence Analysis at IBCP
Web site. This conformation change could have func-
tional consequences.
Cirhin is classified in NCBI LocusLink as a WD re-
peat–containing protein. The secondary-structure pre-
dictions used detected 10 WD repeats. WD proteins are
involved in signal transduction, chromatin assembly,
mRNA synthesis, RNA splicing, vascular trafficking, cy-
toskeletal assembly, transcription initiation complex as-
sembly, and, often, the organization of proteins into
complexes (Smith et al. 1999). The R565W mutation
lies outside of the predicted WD domains.
Most genes previously described as causing familial
cholestases are implicated in membrane transport of bile
components (Li et al. 1997; Bull et al. 1998; de Vree et
al. 1998; Strautnieks et al. 1998; Jansen and Muller
2000). Because Cirhin has no apparent connection with
biliary function, it may provide new insights into the
mechanisms of cholestasis.
Molecular studies of Canadian First Nations are pro-
viding useful tools for diagnosis and therapy (Robinson
et al. 1984; Greenberg et al. 1995; Weiler et al. 1996;
Camacho et al. 1999; Meira et al. 2000; Hegele 2001;
Mok et al. 2002; Triggs-Raine et al. 2002). To our
knowledge, this is the first time that gene function has
been established exclusively by the study of DNA sam-
ples of North American aboriginal populations. Con-
versely, the discovery that a single major mutation causes
NAIC will provide a useful genetic counseling tool for
individuals from at-risk communities. In addition, there
are many cases of nonsyndromic cholestasis with un-
known molecular defect in which the Cirhin gene can
now be investigated.
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